Nyra Medical develops the CARLEN transcatheter technology to treat mitral regurgitation. CARLEN is designed to preserve physiological valve geometry while restoring valve function, eliminate the risk of stenosis, and preserve a full range of future transcatheter and surgical treatment options. The company intends to use the financing to advance the technology through early feasibility clinical studies. Nyra was founded by Murali Padala and is based in Atlanta, GA. In conjunction with the financing the company added Lisa Wipperman Heine to its board as an independent director. The company raised $20M in a Series A financing.

Total raised

$20M

Funding rounds

1

Latest round

Series A

Latest activity

Nov 2022